In Brief
Refine Search
Pharmaceutical
Danish drugmaker Novo Nordisk has announced new results from the STEP Phase IIIa clinical trial program. 13 May 2021
Biotechnology
Los Angeles-based Appia Bio has launched with a $52 million series A financing led by 8VC. 11 May 2021
Pharmaceutical
Fortress Biotech is to make an upfront payment to Fuji Yakuhin for rights to develop and commercialize dotinurad. 11 May 2021
Biotechnology
German biotech BioNTech today revealed that total revenues for the first-quarter of 2021 were estimated to be 2,048.4 million euros (~$3 billion) compared to 27.7 million euros for the like three months of 2020. 10 May 2021
Biotechnology
AI-driven gene therapy specialist Dyno Therapeutics has raised $100 million in a series A financing round led by investment company Andreessen Horowitz. 6 May 2021
Pharmaceutical
Based on high demand expected to continue throughout the year and a very strong first quarter of 2021 with net sales of 4.63 billion euros ($5.59 billion) resulting in earnings before interest, taxes, depreciation and amortization (EBITDA) pre of 1.51 billion euros and earnings per share (EPS) pre of 2.18 euros, Germany’s Merck KGaA has raised its forecast for the entire group for fiscal 2021. 5 May 2021
Biotechnology
The European Medicines Agency (EMA) has initiated a rolling review of Sinovac’s COVID-19 vaccine, Vero Cell, based on preliminary results and data from clinical studies. 4 May 2021
Pharmaceutical
Seattle, USA-based Amcyte Pharma announced results of a multi-center, placebo-controlled trial in which its iota carrageenan nasal spray Nasitrol reduced COVID-19 infection among unvaccinated ICU staff who care for COVID patients, compared with placebo. 3 May 2021
Pharmaceutical
A proposal to waive intellectual property rights for COVID-19 vaccines and treatments left a World Trade Organization Intellectual Property (IP) panel deadlocked again Friday, but proponents said they will revise the plan to find common ground, which the committee's chairman said was cause for "careful optimism,” writes Ryan Davis on LAW360, a LexisNexis company. 3 May 2021
Biotechnology
Danish biotech Adcendo, which is developing antibody-drug conjugates (ADCs) for the treatment of cancers, today announced the successful closing of a 51 million euros ($ 62 million) Series A financing. 29 April 2021
Pharmaceutical
The major Chinese city Shanghai has launched its local version of Hui Min Bao, a government-backed, commercial insurance company underwritten healthcare insurance product that is complement to China's current national social healthcare scheme. 28 April 2021
Pharmaceutical
Indian contract research, development and manufacturing organization Syngene has extended its research collaboration with US pharma major Bristol Myers Squibb through the end of 2030. 28 April 2021
Pharmaceutical
Professor Kristian Helin, a world-leading cancer researcher with exceptional leadership experience in three different countries, will become chief executive of the UK’s Institute of Cancer Research, in September. 28 April 2021
Biotechnology
British life sciences group 4basebio UK Societas has signed an R&D and licensing deal with Royal Holloway University of London (RHUL), targeting a novel gene therapy for treatment of Duchenne muscular dystrophy (DMD). 27 April 2021
Biotechnology
The US Food and Drug Administration and the US Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson COVID-19 vaccine in the USA should be lifted and use of the vaccine should resume. 24 April 2021
Biotechnology
Japan’s Mitsubishi Tanabe Pharma has filed a new drug application (NDA) in Japan for the VMAT2 inhibitor valbenazine to treat tardive dyskinesia. 23 April 2021
Pharmaceutical
German pharmaceutical firm medac Pharma has been given “special arrangements” status by the UK’s health technology assessor, for an innovative chemosaturation therapy. 23 April 2021
Biotechnology
Egypt’s Minapharm and its Berlin-based subsidiary ProBioGen have agreed to establish a manufacturing base for Russia’s homegrown coronavirus vaccine, Sputnik V. 22 April 2021
Biotechnology
The Serum Institute of India (SII) said yesterday it welcomes the recent announcement made by India’s Ministry of Health and Finance Ministry to accelerate India’s vaccination drive. The promising directives will help to scaleup vaccine production, and allow state governments, private hospitals, and vaccination centers to procure vaccines directly. 22 April 2021
Pharmaceutical
Californian immunology specialist Vera Therapeutics has appointed Celia Lin as chief medical officer. The firm has also appointed Tad Thomas as product development head and Joseph Young as SVP of finance. 21 April 2021
Biotechnology
Japanese drugmaker Takeda has launched Fruzaqla (fruquintinib) in its home country. 22 November 2024
Biotechnology
Chinese biopharma CStone Pharmaceuticals has announced a strategic commercial collaboration with Pharmalink Store, a prominent pharmaceutical company based in the United Arab Emirates (UAE). 22 November 2024
Biotechnology
Zhongshan-based biopharma company Akeso will await the verdict of the Chinese medicines regulator on a penpulimab-based combo therapy. 22 November 2024
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Pharmaceutical
Shanghai-based Zai Lab and New York’s Pfizer are to work together on the commercialization of Xacduro (sulbactam-durlobactam) in China. 22 November 2024
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
British pharma major AstraZeneca is facing challenges in its bid to secure full approval for its anticoagulant reversal therapy, Andexxa (andexanet alfa), in the USA. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
Privately-held US biotech Alloy Therapeutics has announced a strategic collaboration and license agreement with Takeda Pharmaceutical. 21 November 2024
Pharmaceutical
Japanese drugmaker Eisai has announced that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection (mecobalamin) has been launched in Japan as a treatment for slowing progression of functional impairment in amyotrophic lateral sclerosis. 21 November 2024
Pharmaceutical
Germany's Merck has spent more than 25 years researching and developing solutions for advancing multiple sclerosis (MS) care. 21 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Pharmaceutical
Swiss pharma giant Novartis today announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. 21 November 2024
Biotechnology
The US Food and Drug Administration (FDA) has granted accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use, say the drug’s developer, Jazz Pharmaceuticals. 21 November 2024
Biotechnology
Eli Lilly is not resting on its laurels when it comes to the fast-growing field of obesity treatments, an area in which it is already a leader. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
Biotechnology
Astellas Pharma has been hit by bad news from the US Food and Drug Administration, which will not currently approve the firm’s request to supplement the label for Izervay (avacincaptad pegol). 21 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze